190 related articles for article (PubMed ID: 7575677)
1. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
Cumming P; Ase A; Diksic M; Harrison J; Jolly D; Kuwabara H; Laliberté C; Gjedde A
Biochem Pharmacol; 1995 Sep; 50(7):943-6. PubMed ID: 7575677
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
[TBL] [Abstract][Full Text] [Related]
3. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
Melega WP; Hoffman JM; Luxen A; Nissenson CH; Phelps ME; Barrio JR
Life Sci; 1990; 47(2):149-57. PubMed ID: 2117691
[TBL] [Abstract][Full Text] [Related]
4. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
[TBL] [Abstract][Full Text] [Related]
5. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
[TBL] [Abstract][Full Text] [Related]
6. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.
Yee RE; Cheng DW; Huang SC; Namavari M; Satyamurthy N; Barrio JR
Biochem Pharmacol; 2001 Nov; 62(10):1409-15. PubMed ID: 11709201
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
11. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
Cumming P; Kuwabara H; Gjedde A
J Neurochem; 1994 Nov; 63(5):1675-82. PubMed ID: 7931323
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Cumming P; Léger GC; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
Cumming P; Häusser M; Martin WR; Grierson J; Adam MJ; Ruth TJ; McGeer EG
Biochem Pharmacol; 1988 Jan; 37(2):247-50. PubMed ID: 3124856
[TBL] [Abstract][Full Text] [Related]
14. Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa.
Pauwels T; Dethy S; Goldman S; Monclus M; Luxen A
Eur J Pharmacol; 1994 May; 257(1-2):53-8. PubMed ID: 8082707
[TBL] [Abstract][Full Text] [Related]
15. 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
DeJesus OT; Haaparanta M; Solin O; Nickles RJ
Brain Res; 2000 Sep; 877(1):31-6. PubMed ID: 10980240
[TBL] [Abstract][Full Text] [Related]
16. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
[TBL] [Abstract][Full Text] [Related]
17. The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: significance in the development of 18F-PETT scanning agents.
Creveling CR; Kirk KL
Biochem Biophys Res Commun; 1985 Aug; 130(3):1123-31. PubMed ID: 3927916
[TBL] [Abstract][Full Text] [Related]
18. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
19. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
[TBL] [Abstract][Full Text] [Related]
20. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]